Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
A person holds a smartphone and points at the screen while health and medicine-related vectors appear in the foreground
At-home, smartphone app-based tests, like other POC tests, are cost-effective, quick, and convenient.

New Smartphone-Based Test to Diagnose Lupus Nephritis

At-home test made as user-friendly and economic as a pregnancy or COVID-19 test

University of Houston
Published:Feb 02, 2023
|2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

A team of researchers at the University of Houston reported the success of their new method for the early diagnosis and monitoring of lupus nephritis—at home. If you’ve taken an at-home COVID-19 or pregnancy test, then you’ve taken what is scientifically called a lateral flow assay (LFA) test, a diagnostic tool widely used because of its rapid results, low cost, and ease of operation. The team applied that same technology to assessing lupus nephritis (LN), or inflammation of the kidneys, one of the most severe complications for patients with systemic lupus erythematosus (SLE). 

The home test—with results read on a smartphone—is meant to eventually replace the gold standard for diagnosis of active LN, an invasive kidney biopsy, which cannot be serially repeated with its attendant morbidity. The test assesses the levels of a protein-coding gene known as ALCAM, or activated leukocyte cell adhesion molecule.  

“Urinary ALCAM (uALCAM) has shown high diagnostic accuracy for renal pathology activity in active lupus nephritis,” reports Chandra Mohan, professor, Biomedical Engineering, and one of the nation’s leading lupus researchers, in Frontiers in Immunology. “The LFA tests for both nonnormalized and normalized uALCAM exhibited excellent accuracies in distinguishing active lupus nephritis from healthy controls.” 

This test had 86 percent accuracy for distinguishing active LN from all other lupus patients. 

Richard Willson, professor of chemical and biomolecular engineering and professor of biochemical and biophysical sciences, created a smartphone app and test kit combining the technology underlying home pregnancy tests and the ALCAM biomarkers discovered by Mohan

“Periodic monitoring of uALCAM using this easy-to-use LFA test by the patient at home could potentially accelerate early detection of renal involvement or disease flares in lupus patients, and hence reduce morbidity and mortality,” said Willson. 

According to the Centers for Disease Control and Prevention, about 204,295 Americans have systemic lupus erythematosus, an autoimmune disease leading to chronic inflammation in multiple organs, including the kidneys. Nephritis flares are hard to recognize because their symptoms often masquerade as something else. One might think they have a cold or the flu, or are just tired. 

“A point-of-care (POC) testing platform’s importance rests on its potential to empower patients to monitor their health status with convenience, thus allowing for early diagnosis and monitoring of disease progression. The LFA represents the most widely used rapid diagnostic POC testing platform,” said Mohan.  

In this work, the team used nanophosphor-based lateral flow immunoassays to demonstrate promise in facilitating home-based smartphone-enabled monitoring of disease activity in LN. “This may allow the proactive institution of therapeutics and even preventive strategies in LN, while minimizing treatment-related side effects,” said Mohan. These studies were carried out by a biomedical graduate student, Rongwei Lei, with clinical support from Michelle Petri, MD, MPH, John Hopkins University School of Medicine.

Other contributors from the University of Houston include Binh Vu and Katerina Kourentzi Vu, William A. Brookshire Department of Chemical and Biomolecular Engineering; Sanam Soomro and Suma Nadimpalli, biomedical engineering; Adheesha N. Danthanarayana and Jakoah Brgoch, Department of Chemistry.  

- This press release was originally published on the University of Houston website